¼¼°èÀÇ ½Å°æÇ÷°ü Ä«Å×ÅÍ ½ÃÀå Á¶»ç º¸°í¼ - »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¹× ¿¹Ãø(2023-2030³â)
Global Neurovascular Catheters Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
»óǰÄÚµå
:
1274373
¸®¼Ä¡»ç
:
Value Market Research
¹ßÇàÀÏ
:
2023³â 05¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 174 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
½Å°æÇ÷°ü Ä«Å×ÅÍ¿¡ ´ëÇÑ ¼¼°è ¼ö¿ä´Â 2022³â 62¾ï ´Þ·¯¿¡¼ 2030³â 115¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2022-2030³â Á¶»ç ±â°£ µ¿¾È 8.12%ÀÇ CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.
½Å°æÇ÷°ü Ä«Å×ÅÍ´Â ³ú¿Í µÎ°³ ³» ºÎÀ§ ¼ö¼ú¿¡ »ç¿ëµÇ¸ç ½Å°æÇ÷°ü Ä¡·á¸¦ À§ÇØ »ç¿ëµË´Ï´Ù. ½Å°æÇ÷°üÀº ¼¶¼¼ÇÑ ±â°üÀ̱⠶§¹®¿¡ ÀÌ·¯ÇÑ Ä¡·á¿¡ »ç¿ëµÇ´Â Ä«Å×ÅÍ´Â Ç÷°ü ¼Õ»óÀ̳ª ÆÄ¿À» ¹æÁöÇϱâ À§ÇØ Æ¯¼öÇÏ°Ô Á¦À۵Ǿú½À´Ï´Ù. µ¿Á¤¸Æ ±âÇü, ³úµ¿¸Æ·ù, »öÀü¼º ³úÁ¹Áß µîÀº ¸ðµÎ ÀÌ Ä«Å×Å͸¦ »ç¿ëÇÏ¿© Ä¡·áÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ Ä«Å×ÅÍ´Â ÈíÀÔ, ½º³×¾î, ·¹ÀÌÀú, ÃÊÀ½ÆÄ µî ±â°èÀû ±â¼úÀ» »ç¿ëÇÏ¿© ³ú½Å°æÇ÷°ü°è¿¡¼ Ç÷ÀüÀ» Á¦°ÅÇÕ´Ï´Ù.
½ÃÀå ¿ªÇÐ :
½Å°æÇ÷°ü Ä«Å×ÅÍ ½ÃÀåÀº ½Å°æÇ÷°ü ÁúȯÀÇ ºóµµ°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½Å°æÁúȯÀÌ º¸Æíȵʿ¡ µû¶ó ÃÖ¼Òħ½ÀÀû ¼ö¼ú¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡ÇÏ¸é¼ ½Å°æÇ÷°ü Ä«Å×ÅÍ ½ÃÀåÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ½ÃÀå °³Ã´À¸·Î ÀÎÇØ ±âÁ¸ ³ú¼ö¼ú ±â¼úÀÌ ´õ ÀÌ»ó »ç¿ëµÇÁö ¾Ê±â ¶§¹®¿¡ ¼ö¿ä Áõ°¡¿Í ÇÔ²² ½Å°æÇ÷°ü Ä«Å×ÅÍ ½ÃÀåÀÌ ¼ºÀåÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÃÖÁ¾ »ç¿ëÀÚÀÇ Çʿ信 µû¶ó ¸ÂÃãÈÇÒ ¼ö ÀÖ´Â À¯¿¬¼ºÀÌ ½Å°æÇ÷°ü Ä«Å×ÅÍÀÇ Ã¤ÅÃÀ» ÃËÁøÇÏ´Â ¿äÀÎ Áß Çϳª·Î ÀÛ¿ëÇÏ¿© ½ÃÀåÀ» È®´ë½Ã۰í ÀÖ½À´Ï´Ù. ½Å°æÇ÷°ü Ä«Å×ÅÍÀÇ »ç¿ëÀº Ä«Å×ÅÍÀÇ ¿ëµµ¿Í ±× À§Ç輺À¸·Î ÀÎÇØ Á¦ÇÑÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ³ôÀº Ä¡·á ºñ¿ë, Áö¿øÀûÀÎ ±ÔÁ¦ ±âÁØÀÇ ºÎÀç, ½Å°æÇ÷°ü Áúȯ Ä¡·áÀ²ÀÇ ÀúÇϰ¡ ½Å°æÇ÷°ü Ä«Å×ÅÍ ½ÃÀå È®´ë¸¦ ÀúÇØÇÏ´Â ¿äÀÎÀÔ´Ï´Ù.
ÀÌ º¸°í¼´Â Porter's Five Forces ¸ðµ¨, ½ÃÀå ¸Å·Âµµ ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â »ê¾÷ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼ °æÀïÀÇ ¸Å·Âµµ¸¦ Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ µµ±¸´Â ¼¼°è ½Å°æÇ÷°ü Ä«Å×ÅÍ ½ÃÀåÀÇ °¢ ºÎ¹®¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ Æò°¡¸¦ Á¦°øÇÕ´Ï´Ù. ½Å°æÇ÷°ü Ä«Å×ÅÍ »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ ¿¬±¸¿¡ ´ëÇÑ ÀüüÀûÀÎ Á¢±Ù ¹æ½ÄÀ» Á¦°øÇÕ´Ï´Ù.
½ÃÀå ¼¼ºÐÈ :
½Å°æÇ÷°ü Ä«Å×ÅÍ ½ÃÀå º¸°í¼´Â ±¹°¡ ¹× Áö¿ªº°·Î ºÎ¹®À» ºÐ¼®ÇÏ°í »ó¼¼ÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇÏ¿© Àü·«°¡µéÀÌ °¢ Á¦Ç° ¹× ¼ºñ½ºÀÇ Å¸°ÙÃþÀ» ½Äº°Çϰí ÇâÈÄ ºñÁî´Ï½º ±âȸ¸¦ âÃâÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù.
À¯Çüº°
- ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ
- dz¼± Ä«Å×ÅÍ
- Á¢±Ù Ä«Å×ÅÍ
- »öÀü¼ú¿ë Ä«Å×ÅÍ
- ±âŸ
ÀÀ¿ë ºÐ¾ßº°
- »öÀü¼º ³úÁ¹Áß
- ³úµ¿¸Æ·ù
- µ¿Á¤¸Æ ±âÇü
- ±âŸ
ÃÖÁ¾»ç¿ëÀÚº°
- º´¿ø
- Áø·á¼Ò
- ¿Ü·¡¼ö¼ú¼¾ÅÍ
- Áø´Ü¼¾ÅÍ
Áö¿ªº° ºÐ¼® :
ÀÌ ¼½¼Ç¿¡¼´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ½Å°æÇ÷°ü Ä«Å×ÅÍ ½ÃÀåÀÇ ÇöÀç ¹× ¹Ì·¡ ¼ö¿ä¸¦ °Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ ¸ðµç ÁÖ¿ä Áö¿ªÀÇ °³º° ¿ëµµ ºÎ¹® ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼´Â ¶ÇÇÑ ½ÃÀå ÁÖ¿ä ±â¾÷ÀÇ Á¾ÇÕÀûÀÎ ÇÁ·ÎÆÄÀϰú ¼¼°è °æÀï ȯ°æ¿¡ ´ëÇÑ »ó¼¼ÇÑ °üÁ¡µµ ´Ù·ç°í ÀÖ½À´Ï´Ù. ½Å°æÇ÷°ü Ä«Å×ÅÍ ½ÃÀåÀÇ ÁÖ¿ä ¾÷ü·Î´Â Medtronic, Stryker, phenox GmbH, Penumbra Inc. Corporation, Biomerics, Acandis GmbH, Spiegelberg GmbH &Co.KGÀÔ´Ï´Ù. ÀÌ ¼½¼ÇÀº ÁÖ¿ä M&A, ¹Ì·¡ ¿ª·®, ÆÄÆ®³Ê½Ê, À繫 °³¿ä, Çù¾÷, ½ÅÁ¦Ç° °³¹ß, ½ÅÁ¦Ç° Ãâ½Ã µî ´Ù¾çÇÑ Àü·«Àû ¹ßÀüÀ» Æ÷ÇÔÇÑ °æÀï ȯ°æÀÇ Àü¹ÝÀûÀÎ °³¿ä·Î ±¸¼ºµÅ ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå ¼¹®
- º» º¸°í¼ÀÇ ³»¿ë
- ¸ñÀû
- ´ë»ó µ¶ÀÚ
- Unique Selling Proposition(USP) ¹× Á¦°ø ¼ºñ½º
- Á¶»ç ¹üÀ§
- Á¶»ç ¹æ¹ý
- ½ÃÀå Á¶»ç °úÁ¤
- ½ÃÀå Á¶»ç ¹æ¹ý
Á¦2Àå ÁÖ¿ä ¿ä¾à
- ½ÃÀå ÇÏÀ̶óÀÌÆ®
- ¼¼°è ½ÃÀå ½º³À¼ô
Á¦3Àå ½Å°æÇ÷°ü Ä«Å×ÅÍ - »ê¾÷ ºÐ¼®
- ¼·Ð - ½ÃÀå ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
- ½ÃÀå ±âȸ
- »ê¾÷ µ¿Çâ
- PorterÀÇ Five Forces ºÐ¼®
- ½ÃÀå ¸Å·Âµµ ºÐ¼®
- ½ÃÀ庰 ¸Å·Â ºÐ¼® : À¯Çüº°
- ½ÃÀ庰 ¸Å·Â ºÐ¼® : ¿ëµµº°
- ½ÃÀ庰 ¸Å·Â ºÐ¼® : ÃÖÁ¾ ¿ëµµº°
- ½ÃÀ庰 ¸Å·Â ºÐ¼® : Áö¿ªº°
Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®
- ¹ë·ùüÀÎ ºÐ¼®
- ¿øÀç·á ºÐ¼®
- ¿øÀç·á ¸®½ºÆ®
- ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
- ÁÖ¿ä ¿øÀç·á °¡°Ý µ¿Çâ
- ÀáÀçÀû ±¸¸ÅÀÚ ¸®½ºÆ®
- ¸¶ÄÉÆÃ Ã¤³Î
- Á÷Á¢ ¸¶ÄÉÆÃ
- °£Á¢ ¸¶ÄÉÆÃ
- ¸¶ÄÉÆÃ Ã¤³Î µ¿Çâ
Á¦5Àå COVID-19 ¹ß»ý¿¡ ÀÇÇÑ ¿µÇ⠺м®
Á¦6Àå ¼¼°èÀÇ ½Å°æÇ÷°ü Ä«Å×ÅÍ ½ÃÀå ºÐ¼® : À¯Çüº°
- À¯Çüº° °³¿ä
- ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
- À¯Çüº° ºÐ¼®
- ¸¶ÀÌÅ©·Î Ä«Å×ÅÍ
- dz¼± Ä«Å×ÅÍ
- Á¢±Ù Ä«Å×ÅÍ
- »öÀü¼ú¿ë Ä«Å×ÅÍ
- ±âŸ
À¯Çüº°
ÀÀ¿ë ºÐ¾ßº°
ÃÖÁ¾»ç¿ëÀÚº°
- º´¿ø
- Áø·á¼Ò
- ¿Ü·¡¼ö¼ú¼¾ÅÍ
- Áø´Ü¼¾ÅÍ
Á¦7Àå ¼¼°èÀÇ ½Å°æÇ÷°ü Ä«Å×ÅÍ ½ÃÀå ºÐ¼® : ¿ëµµº°
- °³¿ä : ¿ëµµº°
- ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
- ºÐ¼® : ¿ëµµº°
- »öÀü¼º ³úÁ¹Áß
- ³úµ¿¸Æ·ù
- µ¿Á¤¸Æ ±âÇü
- ±âŸ
Á¦8Àå ¼¼°èÀÇ ½Å°æÇ÷°ü Ä«Å×ÅÍ ½ÃÀå ºÐ¼® : ÃÖÁ¾ ¿ëµµº°
- ÃÖÁ¾ ¿ëµµº° °³¿ä
- ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
- ÃÖÁ¾ ¿ëµµº° ºÐ¼®
- º´¿ø
- Áø·á¼Ò
- ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
- Áø´Ü¼¾ÅÍ
Á¦9Àå ¼¼°èÀÇ ½Å°æÇ÷°ü Ä«Å×ÅÍ ½ÃÀå ºÐ¼® : Áö¿ªº°
- Áö¿ªº° Àü¸Á
- ¼·Ð
- ºÏ¹Ì ÆÇ¸Å ºÐ¼®
- °³¿ä, ÆÇ¸Å ½ÇÀû°ú ¿¹Ãø ºÐ¼® ÆÇ¸Å·® ºÐ¼®
- ºÏ¹Ì ºÎ¹®º° ÆÇ¸Å ºÐ¼®
- ºÏ¹Ì ±¹°¡º° ÆÇ¸Å ºÐ¼®
- ¹Ì±¹ ÆÇ¸Å ºÐ¼®
- ij³ª´Ù ÆÇ¸Å·® ºÐ¼®
- ¸ß½ÃÄÚ ÆÇ¸Å ºÐ¼®
- À¯·´ ÆÇ¸Å·® ºÐ¼®
- °³¿ä, ÆÇ¸Å ½ÇÀû°ú ¿¹Ãø ºÐ¼® ÆÇ¸Å·® ºÐ¼®
- À¯·´ ºÎ¹®º° ÆÇ¸Å ºÐ¼®
- À¯·´ ±¹°¡º° ÆÇ¸Å ºÐ¼®
- ¿µ±¹ ÆÇ¸Å·® ºÐ¼®
- ÇÁ¶û½º ÆÇ¸Å·® ºÐ¼®
- µ¶ÀÏ ÆÇ¸Å ºÐ¼®
- ÀÌÅ»¸®¾Æ ÆÇ¸Å ºÐ¼®
- ·¯½Ã¾Æ ÆÇ¸Å·® ºÐ¼®
- ±âŸ À¯·´ ÆÇ¸Å·® ºÐ¼®
- ¾Æ½Ã¾ÆÅÂÆò¾ç ÆÇ¸Å ºÐ¼®
- °³¿ä, ÆÇ¸Å ½ÇÀû°ú ¿¹Ãø ºÐ¼® ÆÇ¸Å·® ºÐ¼®
- ¾Æ½Ã¾ÆÅÂÆò¾ç ºÎ¹®º° ÆÇ¸Å ºÐ¼®
- ¾Æ½Ã¾ÆÅÂÆò¾ç ±¹°¡º° ÆÇ¸Å ºÐ¼®
- Áß±¹ ÆÇ¸Å ºÐ¼®
- Àεµ ÆÇ¸Å ºÐ¼®
- ÀϺ» ÆÇ¸Å ºÐ¼®
- Çѱ¹ ÆÇ¸Å ºÐ¼®
- È£ÁÖ ÆÇ¸Å·® ºÐ¼®
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç ÆÇ¸Å·® ºÐ¼®
- ¶óƾ¾Æ¸Þ¸®Ä« ÆÇ¸Å ºÐ¼®
- °³¿ä, ÆÇ¸Å ½ÇÀû°ú ¿¹Ãø ºÐ¼® ÆÇ¸Å·® ºÐ¼®
- ¶óƾ¾Æ¸Þ¸®Ä« ºÎ¹®º° ÆÇ¸Å ºÐ¼®
- ¶óƾ¾Æ¸Þ¸®Ä« ±¹°¡º° ÆÇ¸Å ºÐ¼®
- ºê¶óÁú ÆÇ¸Å·® ºÐ¼®
- ¾Æ¸£ÇîÆ¼³ª ÆÇ¸Å·® ºÐ¼®
- Æä·ç ÆÇ¸Å ºÐ¼®
- Ä¥·¹ ÆÇ¸Å ºÐ¼®
- ±âŸ ¶óƾ¾Æ¸Þ¸®Ä« ÆÇ¸Å ºÐ¼®
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ÆÇ¸Å ºÐ¼®
- °³¿ä, ÆÇ¸Å ½ÇÀû°ú ¿¹Ãø ºÐ¼® ÆÇ¸Å·® ºÐ¼®
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ºÎ¹®º° ÆÇ¸Å ºÐ¼®
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ±¹°¡º° ÆÇ¸Å ºÐ¼®
- »ç¿ìµð¾Æ¶óºñ¾Æ ÆÇ¸Å ºÐ¼®
- ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE) ÆÇ¸Å·® ºÐ¼®
- À̽º¶ó¿¤ ÆÇ¸Å·® ºÐ¼®
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹ ÆÇ¸Å ºÐ¼®
- ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ÆÇ¸Å ºÐ¼®
Á¦10Àå ½Å°æÇ÷°ü Ä«Å×ÅÍ ±â¾÷ °æÀï ±¸µµ
- ½Å°æÇ÷°ü Ä«Å×ÅÍ ½ÃÀå °æÀï
- ÆÄÆ®³Ê½Ê/Çù·Â/°è¾à
- ÀμöÇÕº´(M&A)
- ½ÅÁ¦Ç° ¹ß¸Å
- ±âŸ °³¹ß
Á¦11Àå ±â¾÷ °³¿ä
- ±â¾÷ Á¡À¯À² ºÐ¼®
- ½ÃÀå ÁýÁßµµ
- Medtronic
- ±â¾÷ °³¿ä
- ±â¾÷ ¼öÀÍ
- Á¦Ç° ¼Ò°³
- ÃÖ±Ù °³¹ß »óȲ
- Stryker
- ±â¾÷ °³¿ä
- ±â¾÷ ¼öÀÍ
- Á¦Ç° Á¤º¸
- ÃÖ±Ù °³¹ß »óȲ
- phenox GmbH
- ±â¾÷ °³¿ä
- ±â¾÷ ¼öÀÍ
- Á¦Ç° Á¤º¸
- ÃÖ±Ù °³¹ß »óȲ
- Penumbra Inc.
- ±â¾÷ °³¿ä
- ±â¾÷ ¼öÀÍ
- Á¦Ç° Á¤º¸
- ÃÖ±Ù °³¹ß »óȲ
- Integer Holdings Corporation
- ±â¾÷ °³¿ä
- ±â¾÷ ¼öÀÍ
- Á¦Ç° Á¤º¸
- ÃÖ±Ù °³¹ß »óȲ
- Terumo Corporation
- ±â¾÷ °³¿ä
- ±â¾÷ ¼öÀÍ
- Á¦Ç° Á¤º¸
- ÃÖ±Ù °³¹ß »óȲ
- Integra LifeSciences Corporation
- ±â¾÷ °³¿ä
- ±â¾÷ ¼öÀÍ
- Á¦Ç° Á¤º¸
- ÃÖ±Ù °³¹ß »óȲ
- Biomerics
- ±â¾÷ °³¿ä
- ±â¾÷ ¼öÀÍ
- Á¦Ç° Á¤º¸
- ÃÖ±Ù °³¹ß »óȲ
- Acandis GmbH
- ±â¾÷ °³¿ä
- ±â¾÷ ¼öÀÍ
- Á¦Ç° Á¤º¸
- ÃÖ±Ù °³¹ß »óȲ
- Spiegelberg GmbH & Co. KG
- ±â¾÷ °³¿ä
- ±â¾÷ ¼öÀÍ
- Á¦Ç° Á¤º¸
- ÃÖ±Ù µ¿Çâ
ÁÖ : ±â¾÷ °³¿ä Áß¿¡¼ À繫 »ó¼¼³ª ÃÖ±Ù °³¹ß¿¡ °ü·ÃµÈ °ÍÀº ÀÔ¼ö °¡´ÉÇÑ Á¤º¸¿¡ ±Ù°ÅÇÑ °ÍÀ̸ç, ºñ°ø°³ ±â¾÷ÀÇ °æ¿ì °ÔÀçµÇÁö ¾ÊÀ» ¼ö ÀÖ½À´Ï´Ù.
LSH
¿µ¹® ¸ñÂ÷
The global demand for Neurovascular Catheters Market is presumed to reach the market size of nearly USD 11.57 BN by 2030 from USD 6.2 BN in 2022 with a CAGR of 8.12% under the study period of 2022 - 2030. Regarding volume, the market was calculated XX Units in 2022 and forecast to touch XX Units by 2030 with a CAGR of XX% during 2023-2030.
Neurovascular catheters are used for operations in the brain and intracranial areas to carry out neurovascular procedures. Since neurovascular organs are delicate, the catheters used for these treatments are specially made to prevent vessel injury and rupture. Arteriovenous malformations, brain aneurysms, embolic strokes, and other conditions can all be treated using these catheters. These catheters use mechanical techniques, including suction, snare, laser, or ultrasound technology to remove blood clots from the cerebral neurovasculature.
Market Dynamics:
The market for neurovascular catheters is expected to grow due to the rising frequency of neurovascular disorders. As neurological disorders become more common, there is an increasing need for minimally invasive procedures and a developing market for neurovascular catheters. Since conventional brain surgery techniques will no longer be employed due to developments, the market for neurovascular catheters will grow as demand rises. The flexibility to be customized to the end user's needs is one of the factors driving the adoption of neurovascular catheters, increasing its market. The use of neurovascular catheters is hampered by the applications for the catheters and the risk they carry. The treatments' high cost, lack of supportive regulatory criteria, and decreased rates of neurovascular disease therapy impede the market expansion for neurovascular catheters.
The report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of neurovascular catheters. The growth and trends of Neurovascular Catheters Industry provide a holistic approach to this study.
Market Segmentation:
This section of the neurovascular catheters market report provides detailed data on the segments by analyzing them at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
- Microcatheters
- Balloon Catheters
- Access Catheters
- Embolization Catheters
- Others
By Application
- Embolic Stroke
- Brain Aneurysm
- Arteriovenous Malformations
- Others
By End-Use
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Diagnostic Centers
Regional Analysis:
This section covers the regional outlook, which accentuates current and future demand for the Neurovascular Catheters market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the neurovascular catheters market include Medtronic, Stryker, phenox GmbH, Penumbra Inc., Integer Holdings Corporation, Terumo Corporation, Integra LifeSciences Corporation, Biomerics, Acandis GmbH, Spiegelberg GmbH & Co. KG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3 . NEUROVASCULAR CATHETERS - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
6 . GLOBAL NEUROVASCULAR CATHETERS MARKET ANALYSIS BY TYPE
- 6.1 Overview by Type
- 6.2 Historical and Forecast Data
- 6.3 Analysis by Type
- 6.4 Microcatheters Historic and Forecast Sales by Regions
- 6.5 Balloon Catheters Historic and Forecast Sales by Regions
- 6.6 Access Catheters Historic and Forecast Sales by Regions
- 6.7 Embolization Catheters Historic and Forecast Sales by Regions
- 6.8 Others Historic and Forecast Sales by Regions
7 . GLOBAL NEUROVASCULAR CATHETERS MARKET ANALYSIS BY APPLICATION
- 7.1 Overview by Application
- 7.2 Historical and Forecast Data
- 7.3 Analysis by Application
- 7.4 Embolic Stroke Historic and Forecast Sales by Regions
- 7.5 Brain Aneurysm Historic and Forecast Sales by Regions
- 7.6 Arteriovenous Malformations Historic and Forecast Sales by Regions
- 7.7 Others Historic and Forecast Sales by Regions
8 . GLOBAL NEUROVASCULAR CATHETERS MARKET ANALYSIS BY END-USE
- 8.1 Overview by End-use
- 8.2 Historical and Forecast Data
- 8.3 Analysis by End-use
- 8.4 Hospitals Historic and Forecast Sales by Regions
- 8.5 Clinics Historic and Forecast Sales by Regions
- 8.6 Ambulatory Surgical Centers Historic and Forecast Sales by Regions
- 8.7 Diagnostic Centers Historic and Forecast Sales by Regions
9 . GLOBAL NEUROVASCULAR CATHETERS MARKET ANALYSIS BY GEOGRAPHY
- 9.1. Regional Outlook
- 9.2. Introduction
- 9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Data Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
- 9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Data Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
- 9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Data Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. Rest Of Asia Pacific Sales Analysis
- 9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Data Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
- 9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Data Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis
10 . COMPETITIVE LANDSCAPE OF THE NEUROVASCULAR CATHETERS COMPANIES
- 10.1. Neurovascular Catheters Market Competition
- 10.2. Partnership/Collaboration/Agreement
- 10.3. Merger And Acquisitions
- 10.4. New Product Launch
- 10.5. Other Developments
11 . COMPANY PROFILES OF NEUROVASCULAR CATHETERS INDUSTRY
- 11.1. Company Share Analysis
- 11.2. Market Concentration Rate
- 11.3. Medtronic
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
- 11.4. Stryker
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
- 11.5. phenox GmbH
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
- 11.6. Penumbra Inc.
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
- 11.7. Integer Holdings Corporation
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
- 11.8. Terumo Corporation
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
- 11.9. Integra LifeSciences Corporation
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
- 11.10. Biomerics
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
- 11.11. Acandis GmbH
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments
- 11.12. Spiegelberg GmbH & Co. KG
- 11.12.1. Company Overview
- 11.12.2. Company Revenue
- 11.12.3. Products
- 11.12.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
°ü·ÃÀÚ·á